Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2026-05-01 16:15:27 ET · period of report 2026-04-29 · accession 0001193125-26-201474 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 16:15 | 2026-04-29 | TCRT | Jerman Michael Allen | Dir | A - Grant | $2.59 | +6,032 | 15.6K | +63% | +$15.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-29 | A | A | 6,032 | $2.59 | 15,621 | D | — | — | (F1) Represents shares of common stock issued in lieu of board fees. |